G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683 | -52.0% | 474,080 | -17.1% | 0.00% | -50.0% |
| Q2 2023 | $1,424 | +20.0% | 571,791 | +29.1% | 0.00% | 0.0% |
| Q1 2023 | $1,187 | -66.2% | 442,975 | -31.5% | 0.00% | -60.0% |
| Q4 2022 | $3,514 | -99.7% | 647,100 | +531.9% | 0.01% | +150.0% |
| Q3 2022 | $1,279,000 | -44.2% | 102,400 | -77.9% | 0.00% | -33.3% |
| Q2 2022 | $2,292,000 | -10.2% | 464,000 | +337.3% | 0.00% | 0.0% |
| Q1 2021 | $2,553,000 | +117.5% | 106,100 | +50.1% | 0.00% | +200.0% |
| Q1 2019 | $1,174,000 | +97.0% | 70,700 | +520.2% | 0.00% | 0.0% |
| Q3 2018 | $596,000 | -49.7% | 11,400 | -64.4% | 0.00% | 0.0% |
| Q2 2018 | $1,186,000 | 0.0% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,186,000 | – | 32,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |